Healthpartners Institute

Healthpartners Institute, a non-profit research organization and subsidiary of Healthpartners, Inc. (Minneapolis, Minnesota), operates as both a prime recipient of federal grants and contracts and as a subcontractor on research awards, delivering clinical epidemiology, vaccine safety surveillance, real-world evidence research, and implementation science services to the National Institutes of Health, CDC, and other public health agencies. The organization competes on a full-and-open basis across federal grant programs (CFDA 93.x series) and task order vehicles without set-aside designations.

Healthpartners Institute's recent federal footprint spans 209 awards with combined potential value of $367.8 million, split evenly between prime (49%) and sub (51%) roles. The organizational structure anchors around research execution in vaccine safety, diabetes management, mental health surveillance, preventive health interventions, and health systems research—all rooted in access to Healthpartners' clinical data and patient populations. Customer concentration is sharply skewed: the CDC Pittsburgh office drives the award volume and dollar magnitude, with 17 awards carrying $366.9 million in combined potential value—almost entirely the Vaccine Safety Datalink (VSD) master IDIQ and its delivery orders. The CDC represents 100% of the top-customer potential-value ranking. Beneath that, the National Institutes of Health National Institute of Dental and Craniofacial Research, National Institute on Aging, and National Heart Lung and Blood Institute each anchor 18–20 awards across the grant portfolio, but those grants carry modest individual ceilings. The Vaccine Safety Datalink master contract, awarded by CDC Pittsburgh in 2022 with a $149 million ceiling and September 2027 completion date, funds three delivery orders to Healthpartners Institute totaling $3.5 million (as of 2024): a $3.1 million order (September 2022–September 2027), a $227,622 order (March 2023–March 2028), and a $105,539 order (September 2023–December 2024).

Beyond VSD, Healthpartners Institute holds prime federal grant awards from NIH institutes funding applied health services research and clinical trials. Representative prime grants include a $4.72 million National Institute of Diabetes and Digestive and Kidney Diseases cooperative agreement (FY2025–FY2028) for diabetic ketoacidosis risk mitigation in type 1 diabetes patients using continuous glucose and ketone monitoring; a $556,160 National Institute of Arthritis and Musculoskeletal and Skin Diseases project grant (September 2024–August 2027) examining integrated rehabilitation and psychological support for ACL reconstruction; and a $199,747 National Institute of Mental Health K23 Mentored Research Grant (April 2026–March 2031) for machine-learning-driven EHR-based predictive models to identify young people with bipolar disorder at risk for severe mood episodes. The organization also executed a $219,885 FDA purchase order (September 2022–December 2023) studying the association between oral transmucosal pain reduction drugs and dental adverse events using integrated real-world data.

The sub-award footprint is substantial and characterizes the organization as an embedded research site within larger academic consortia. Healthpartners Institute subcontracts to university-led grants from University of Pittsburgh, Kaiser Foundation Hospitals, Michigan State University, University of Minnesota, Wake Forest University Health Sciences, Case Western Reserve University, and others—typically in roles such as site principal investigator, data extraction and analysis provider, or recruitment and enrollment coordinator. Representative sub-award relationships include a role on a Kaiser Permanente-led National Institute of Mental Health study (2024–2026) modeling machine learning for antidepressant treatment personalization, participation in a University of Pittsburgh-led multi-site surgical timing and rehabilitation trial for multiple ligament knee injuries (with sub-awards spanning FY2024–FY2025), and enrollment and site coordination on a Michigan State University suicide prevention study linking health care and criminal justice data (FY2025–2026).

Activity trajectory shows growth through FY2024, reaching 44 awards, then moderating to 28 in FY2025 and 7 in the first half of FY2026. Eight awards carry ultimate completion dates within the next twenty-four months with combined potential value of $3.4 million, representing moderate recompete exposure. SCI-reported invoiced revenue on prime federal service contracts (a partial and conservative measure, capturing only contracts above the $150,000 threshold and excluding grant revenue) totaled $2.4 million across FY2022–FY2024, with $1.1 million in FY2022 and $1.3 million in FY2024; FY2023 reported no SCI-covered invoicing. Across those SCI-reportable prime contracts, government-paid rates median around $138/hr, with senior labor spanning into the $210/hr range. On prime SCI contracts, subcontractors comprised roughly 7% of total contractor hours on average, with ten named subs, indicating that Healthpartners Institute builds most of its federal research delivery in-house using its own clinical and research staff. The organization's federal role centers on leveraging its integrated health system—clinical data access, patient recruitment capacity, and embedded research infrastructure—to support NIH and CDC research and vaccine safety surveillance rather than on technology services or IT contracting.